Qidong Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qidong Cai has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Xiang Wang
Department of Thoracic Surgery, the Second Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Boxue He
Department of Thoracic Surgery, the Second Xiangya Hospital of Central South University, 410011, Changsha, Hunan, China; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, the Second Xiangya Hospital of Central South University, 410011, Changsha, Hunan, China
1 shared publication Christopher Wang
Department of Thoracic Surgery, the Second Xiangya Hospital of Central South University, 410011, Changsha, Hunan, China; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, the Second Xiangya Hospital of Central South University, 410011, Changsha, Hunan, China
1 shared publicationCong Li
Department of Radiology, The Second Xiangya Hospital of Central South University Department of Radiology, Changsha, Hunan, China
1 shared publication- Fenglei Yu
Department of Thoracic Surgery, the Second Xiangya Hospital, Central South University, Changsha, China
1 shared publication - Li Wang
State Key Laboratory of Powder Metallurgy Central South University Changsha China
1 shared publication
Latest Publications
- 30 January 2025
- Published by Elsevier in Cancer Letters
- Vol. 613, 217503
The YTHDF3-DT/miR-301a-3p /INHBA axis attenuates autophagy-dependent ferroptosis in lung adenocarcinoma
- 30 January 2025
- Published by Elsevier in Cancer Letters
- Vol. 613, 217503
The YTHDF3-DT/miR-301a-3p /INHBA axis attenuates autophagy-dependent ferroptosis in lung adenocarcinoma
- Open Access
- 4 June 2024
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 11 (1) , e002148
Shared genetic aetiology of respiratory diseases: a genome-wide multitraits association analysis
Objective This study aims to explore the common genetic basis between respiratory diseases and to identify shared molecular and biological mechanisms. Methods This genome-wide pleiotropic association study uses multiple statistical methods to systematically analyse the shared genetic basis between five respiratory diseases (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, lung cancer and snoring) using the largest publicly available genome wide association studies summary statistics. The missions of this study are to evaluate global and local genetic correlations, to identify pleiotropic loci, to elucidate biological pathways at the multiomics level and to explore causal relationships between respiratory diseases. Data were collected from 27 November 2022 to 30 March 2023 and analysed from 14 April 2023 to 13 July 2023. Main outcomes and measures The primary outcomes are shared genetic loci, pleiotropic genes, biological pathways and estimates of genetic correlations and causal effects. Results Significant genetic correlations were found for 10 paired traits in 5 respiratory diseases. Cross-Phenotype Association identified 12 400 significant potential pleiotropic single-nucleotide polymorphism at 156 independent pleiotropic loci. In addition, multitrait colocalisation analysis identified 15 colocalised loci and a subset of colocalised traits. Gene-based analyses identified 432 potential pleiotropic genes and were further validated at the transcriptome and protein levels. Both pathway enrichment and single-cell enrichment analyses supported the role of the immune system in respiratory diseases. Additionally, five pairs of respiratory diseases have a causal relationship. Conclusions and relevance This study reveals the common genetic basis and pleiotropic genes among respiratory diseases. It provides strong evidence for further therapeutic strategies and risk prediction for the phenomenon of respiratory disease comorbidity.
- 4 June 2024
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 11 (1) , e002148
Open AccessShared genetic aetiology of respiratory diseases: a genome-wide multitraits association analysis
Objective This study aims to explore the common genetic basis between respiratory diseases and to identify shared molecular and biological mechanisms. Methods This genome-wide pleiotropic association study uses multiple statistical methods to systematically analyse the shared genetic basis between five respiratory diseases (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, lung cancer and snoring) using the largest publicly available genome wide association studies summary statistics. The missions of this study are to evaluate global and local genetic correlations, to identify pleiotropic loci, to elucidate biological pathways at the multiomics level and to explore causal relationships between respiratory diseases. Data were collected from 27 November 2022 to 30 March 2023 and analysed from 14 April 2023 to 13 July 2023. Main outcomes and measures The primary outcomes are shared genetic loci, pleiotropic genes, biological pathways and estimates of genetic correlations and causal effects. Results Significant genetic correlations were found for 10 paired traits in 5 respiratory diseases. Cross-Phenotype Association identified 12 400 significant potential pleiotropic single-nucleotide polymorphism at 156 independent pleiotropic loci. In addition, multitrait colocalisation analysis identified 15 colocalised loci and a subset of colocalised traits. Gene-based analyses identified 432 potential pleiotropic genes and were further validated at the transcriptome and protein levels. Both pathway enrichment and single-cell enrichment analyses supported the role of the immune system in respiratory diseases. Additionally, five pairs of respiratory diseases have a causal relationship. Conclusions and relevance This study reveals the common genetic basis and pleiotropic genes among respiratory diseases. It provides strong evidence for further therapeutic strategies and risk prediction for the phenomenon of respiratory disease comorbidity.